Polpharma Dry Forms II Production Facility, Poland
Polpharma began production at its new Dry Forms II plant (Oddzial Formy Suche II – FSII Solid Forms Branch) in ...
Polpharma began production at its new Dry Forms II plant (Oddzial Formy Suche II – FSII Solid Forms Branch) in ...
GSK Biologicals, the vaccine division of the pharmaceutical and healthcare company GlaxoSmithKline (GSK), announced its decision to build a new ...
Cordis Corporation was established in Miami in Florida, US in 1959. The company is a subsidiary of the pharmaceutical major ...
Bidachem SPA is one of the major manufacturers of fine chemicals and active pharmaceutical ingredients (APIs) in Italy. The company ...
Signifor (SOM230 / Pasireotide) is a somatostatin analogue indicated for the treatment of patients with Cushing's disease for whom surgery ...
Under development by Amarin Corporation, AMR101 is a partially synthetic omega-3 fatty acid-based drug. It contains the purest form of ...
Navidea Biopharmaceuticals Inc. has licensed its radioactive cancer diagnostic aid Lymphoseek to a Chinese pharmaceutical company that will have exclusive ...
Navidea Biopharmaceuticals Inc. has licensed its radioactive cancer diagnostic aid Lymphoseek to a Chinese pharmaceutical company that will have exclusive ...
GlaxoSmithKline's ViiV Healthcare has received marketing authorisation from the European Commission (EC) for its Triumeq (dolutegravir 50mg/abacavir 600mg/lamivudine 300mg) tablets ...
Researchers at UCC have developed a microneedle-based patch that results in increased vaccine-induced protection against malaria infection using lower doses ...
Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.
© 2017 Copyright © Valuemediaservices 2017 All rights reserved.